These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 27509825)

  • 41. VLA-4-dependent myeloma cell adhesion.
    Sanz-Rodríguez F; Teixidó J
    Leuk Lymphoma; 2001 Apr; 41(3-4):239-45. PubMed ID: 11378537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ADAM disintegrin-like domain recognition by the lymphocyte integrins alpha4beta1 and alpha4beta7.
    Bridges LC; Sheppard D; Bowditch RD
    Biochem J; 2005 Apr; 387(Pt 1):101-8. PubMed ID: 15504110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice.
    Sabile AA; Arlt MJ; Muff R; Bode B; Langsam B; Bertz J; Jentzsch T; Puskas GJ; Born W; Fuchs B
    J Bone Miner Res; 2012 Jan; 27(1):58-67. PubMed ID: 21976359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immobilized stromal cell-derived factor-1alpha triggers rapid VLA-4 affinity increases to stabilize lymphocyte tethers on VCAM-1 and subsequently initiate firm adhesion.
    DiVietro JA; Brown DC; Sklar LA; Larson RS; Lawrence MB
    J Immunol; 2007 Mar; 178(6):3903-11. PubMed ID: 17339490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blocking of integrin-mediated human MV3 melanoma cell binding by commercial and modified heparins.
    Schlesinger M; Naggi A; Torri G; Zeisig R; Alexander M; Schmitz P; Casu B; Bendas G
    Int J Clin Pharmacol Ther; 2010 Jul; 48(7):448-50. PubMed ID: 20557840
    [No Abstract]   [Full Text] [Related]  

  • 46. Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin function.
    García-Bernal D; Redondo-Muñoz J; Dios-Esponera A; Chèvre R; Bailón E; Garayoa M; Arellano-Sánchez N; Gutierrez NC; Hidalgo A; García-Pardo A; Teixidó J
    J Pathol; 2013 Jan; 229(1):36-48. PubMed ID: 22711564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyr61 induces the expression of monocyte chemoattractant protein-1 via the integrin ανβ3, FAK, PI3K/Akt, and NF-κB pathways in retinal vascular endothelial cells.
    You JJ; Yang CH; Yang CM; Chen MS
    Cell Signal; 2014 Jan; 26(1):133-40. PubMed ID: 24063814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyr61 increases matrix metalloproteinase-3 expression and cell motility in human oral squamous cell carcinoma cells.
    Chuang JY; Yu NY; Chiang IP; Lai CH; Lin CD; Tang CH
    J Cell Biochem; 2012 Jun; 113(6):1977-86. PubMed ID: 22253074
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 1,25-Dihydroxyvitamin D3 suppresses the expression of the VCAM-1 receptor, VLA-4 in human leukemic HL-60 cells.
    Kaneko A; Suzuki S; Hara M; Mori J; Kumagai M; Yajima H; Yamashita K; Kakizawa T; Yamazaki M; Takeda T; Miyamoto T; Ichikawa K; Hashizume K
    Biochem Biophys Res Commun; 1999 Feb; 255(2):371-6. PubMed ID: 10049715
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Relationship of cysteine-rich protein 61 and NF-kappaB expression with metastasis and prognosis of gastric carcinoma].
    Ma HF; Zhao ZS
    Zhonghua Bing Li Xue Za Zhi; 2008 Dec; 37(12):815-21. PubMed ID: 19159527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyr61: a potential therapeutic target for prostate cancer.
    Lin CM; Liang CZ
    Asian J Androl; 2014; 16(5):788-9. PubMed ID: 24759589
    [No Abstract]   [Full Text] [Related]  

  • 52. Contribution of very late antigen-4 (VLA-4) integrin to cancer progression and metastasis.
    Schlesinger M; Bendas G
    Cancer Metastasis Rev; 2015 Dec; 34(4):575-91. PubMed ID: 25564456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The matricellular ligand Cyr61 contributes to the metastatic spread of tumors by activating integrin VLA-4, independently of thiol redox modulation
.
    Hoß SG; Schlesinger M; Bendas G
    Int J Clin Pharmacol Ther; 2017 Aug; 55(8):682-685. PubMed ID: 27509825
    [No Abstract]   [Full Text] [Related]  

  • 54. Cyr61 is a target for heparin in reducing MV3 melanoma cell adhesion and migration via the integrin VLA-4.
    Schmitz P; Gerber U; Schütze N; Jüngel E; Blaheta R; Naggi A; Torri G; Bendas G
    Thromb Haemost; 2013 Nov; 110(5):1046-54. PubMed ID: 24009013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ligand binding of leukocyte integrin very late antigen-4 involves exposure of sulfhydryl groups and is subject to redox modulation.
    Liu SY; Tsai MY; Chuang KP; Huang YF; Shieh CC
    Eur J Immunol; 2008 Feb; 38(2):410-23. PubMed ID: 18196516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Redox modulation of adjacent thiols in VLA-4 by AS101 converts myeloid leukemia cells from a drug-resistant to drug-sensitive state.
    Layani-Bazar A; Skornick I; Berrebi A; Pauker MH; Noy E; Silberman A; Albeck M; Longo DL; Kalechman Y; Sredni B
    Cancer Res; 2014 Jun; 74(11):3092-103. PubMed ID: 24699624
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.